Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Dropout: a simple way to prevent neural networks from overfitting
2014 StandoutNobel
Rectified Linear Units Improve Restricted Boltzmann Machines
2010 StandoutNobel
Epidemiology of hepatitis B virus infection in India.
1996
Genetic variability: The key problem in the prevention and therapy of RNA‐based virus infections
2003
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
A Study of Serological Markers of Hepatitis B and C Viruses in Istanbul, Turkey
2003
Incidence and Risk Factors for Acute Hepatitis B in the United States, 1982–1998: Implications for Vaccination Programs
2002
A mathematical model to estimate global hepatitis B disease burden and vaccination impact
2005
Contagious Acute Gastrointestinal Infections
2004
Neonatal Deaths After Hepatitis B Vaccine
1999
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Hepatitis C Virus Infection
2001 Standout
Rapid Antibody Response after Vaccination with a Virosomal Hepatitis A Vaccine
2004
Impact of hepatitis B immunization, Europe and worldwide
2003
Hepatitis B Virus Infection: Epidemiology and Vaccination
2006 Standout
Intimate partner violence: causes and prevention
2002 Standout
Sexual dimorphism of humoral immunity with human vaccines
2008
Tho Sequential Outbreaks of Rotavirus Gastroenteritis: Evidence for Symptomatic and Asymptomatic Reinfections
1988
Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?
1997
Human-level control through deep reinforcement learning
2015 StandoutNatureNobel
Hepatitis C vaccine: supply and demand
2008
The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C
2000
Induction of mucosal immunity through systemic immunization: Phantom or reality?
2016
Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis
1997
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Hepatitis B virus infection
2009 Standout
Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
1998
What Makes Clinical Research Ethical?
2000 Standout
Safety of neonatal hepatitis B vaccine administration
2001
Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr
1996
Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries1Prepared as a review for the Consensus Workshop on Rotavirus Vaccines for use in Developing Countries, Geneva, January 9–10, 1997. Sponsored by: The Global Programme for Vaccines, World Health Organization, The Children's Vaccine Initiative and the Centers for Disease Control and Prevention.1
1999
Hepatitis B vaccines
2003
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy
2011
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Age‐dependent variation in the serum concentration of mannan‐binding protein
1996
Neonatal and early life vaccinology
2001
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
1998
Diabetes in Asia
2009 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
2015
Immunopathology of multiple sclerosis
2015 Standout
The Xs and Y of immune responses to viral vaccines
2010
Access to Essential Drugs in Poor Countries
1999 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Human papillomavirus and cervical cancer
2007 Standout
Efficacy of an Accelerated Hepatitis B Vaccination Program During Pregnancy
2011
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
Chronic hepatitis B
2007 Standout
Immunogenicity of Hepatitis B vaccines
1998
Chronic hepatitis B: Update 2009 #
2009 Standout
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants
2013
Comparative Safety of Two Recombinant Hepatitis B Vaccines in Children
1998
Socioeconomic determinants of health : Health and social cohesion: why care about income inequality?
1997
Vaccination greatly reduces disease, disability, death and inequity worldwide
2008 Standout
Immunogenicity of a chimeric hepatitis A virus (HAV) carrying the HIV gp41 epitope 2F5
2006
Representation Learning: A Review and New Perspectives
2013 Standout
Nationwide Hepatitis B Vaccination Program in Taiwan: Effectiveness in the 20 Years After It Was Launched
2006
Innate immunity of the newborn: basic mechanisms and clinical correlates
2007 Standout
Sex differences in immune responses
2016 Standout
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Prognostic value of gated myocardial perfusion SPECT
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Global Epidemiology of Hepatitis B Virus
2004
Modeling Natural Images Using Gated MRFs
2013 StandoutNobel
Rotavirus Disease in Finnish Children: Use of Numerical Scores for Clinical Severity of Diarrhoeal Episodes
1990
Rotavirus Infection in Infants as Protection against Subsequent Infections
1996 Standout
A Cell Culture Adapted HCV JFH1 Variant That Increases Viral Titers and Permits the Production of High Titer Infectious Chimeric Reporter Viruses
2012
SARS-CoV-2 vaccines in development
2020 StandoutNature
Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review
2012
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine
2001
Successful Vaccine-Induced Seroconversion by Single-Dose Immunization in the Presence of Measles Virus-Specific Maternal Antibodies
2000
What is the best multi-stage architecture for object recognition?
2009
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP): Part 1: Immunization of Infants, Children, and Adolescents
2005
Hepatitis B vaccination for patients with chronic renal failure
2004
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During Infancy
2007
Deep learning for AI
2021 StandoutNobel
ImageNet classification with deep convolutional neural networks
2017 StandoutNobel
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
2018
Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1999 Standout
Response to hepatitis B vaccination in patients with liver cirrhosis
2017
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
A Single Nucleotide Change in the 5′ Noncoding Region of Sindbis Virus Confers Neurovirulence in Rats
1999 StandoutNobel
Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood
1990
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Gluten Intake Interferes With the Humoral Immune Response to Recombinant Hepatitis B Vaccine in Patients With Celiac Disease
2008
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins
2002 StandoutNobel
Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests
2000
Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cells
1994
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Works of Francis André being referenced
Simultaneous vaccination against hepatitis A and B: results of a controlled study
1992
Factors Affecting Antibody Response of Newborns to Repeated Administrations of the Rotavirus Vaccine RIT 4237
1987
Hepatitis B epidemiology in Asia, the Middle East and Africa
2000
Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine
1992
Is there a causal link between hepatitis B vaccination and multiple sclerosis?
2000
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers
1990
Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use
2002
Multicentre dose range study of a yeast-derived hepatitis B vaccine
1987
Evaluation of RIT 4237 Bovine Rotavirus Vaccine in Newborn Infants: Correlation of Vaccine Efficacy to Season of Birth in Relation to Rotavirus Epidemic Period
1990
Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers
1993
Protective efficacy of hepatitis B vaccines in neonates
1994
Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients
1989
Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine
1990
Measles, mumps and rubella immunization at nine months in a developing country
1990
Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus Diarrhoea
1991
Universal Mass Vaccination Against Hepatitis A
2006
Interruption of an outbreak of hepatitis A in two villages by vaccination
1994
Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings
1992
Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity
1994
Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine
1989
Safety and immunogenicity of hepatitis A vaccine in healthy children
1993
Long-term prognostic value of 201Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stenting
2001
Protection of Peruvian Children Against Rotavirus Diarrhea of Specific Serotypes by One, Two, or Three Doses of the RIT 4237 Attenuated Bovine Rotavirus Vaccine
1989
What can be done to make vaccines more trendy?
2005
Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic
1985
Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants
1985
Inactivated candidate vaccines for hepatitis A.
1990
Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine.
1987
Measurement of intestinal permeability to mannitol and lactulose as a means of diagnosing food allergy and evaluating therapeutic effectiveness of disodium cromoglycate.
1987
Immunogenicity of a recombinant DNA hepatitis B vaccine in neonates.
1987